Skip to main content

Evaluation of a DNA Extraction and Purification Protocol Using Archived Formalin-fixed Paraffin-embedded Tissues for BRAF Mutations Analysis in Papillary Thyroid Microcarcinomas.

Nechifor-Boilă A, Loghin A, Descotes F, Decaussin-Petrucci M, Borda A

Publication: Appl Immunohistochem Mol Morphol (2019) • Vol 27 • Page 70-76PMID: 28549037View on PubMed

Purpose

This paper investigated the effects of formalin-fixed, paraffin-embedded (FFPE) block storage duration (1, 2, 3, or 4 years) and papillary thyroid tumor size on DNA concentration and purity and BRAF gene mutation detection by real-time RT-PCR. Differences in tumor size, block storage duration, DNA concentration, and DNA purity between BRAF-negative and BRAF-positive tumor specimens were also assessed.

Conclusion

DNA concentration, DNA purity, GAPDH crossing point (Cp) values, and BRAF gene Cp values were comparable between specimens from tumors ≤5 mm and tumors >5 mm and were not affected by FFPE block storage duration or BRAF mutation status.

Studies (1)

Purpose

This study investigated the effects of FFPE papillary thyroid tumor block storage duration (1, 2, 3, or 4 years) and tumor size on DNA concentration and purity and BRAF gene mutation detection by real-time RT-PCR. Differences in tumor size, block storage duration, DNA concentration, and DNA purity between BRAF-negative and BRAF-positive tumor specimens were also assessed. Specimens from 25 patients with papillary thyroid microcarcinomas (PTMCs) undergoing surgery were immediately fixed in neutral buffered formalin for 48-72 hours (depending on the size of the specimen), paraffin embedded, and stored as blocks at room temperature for 1, 2, 3, or 4 years. Five 4-µm thick sections were obtained from each block, deparaffinized using xylene, and DNA was extracted using a MasterPure DNA Purification Kit. DNA yield (A260 nm) and purity (A260 nm/A280 nm) were assessed by spectrophotometry. The 15th exon of the BRAF gene and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were amplified by real-time RT-PCR. The Cp was defined as the PCR cycle at which fluorescence was first detected. BRAF gene mutation status was assessed by high-resolution melting analysis and confirmed by Sanger sequencing.

Summary of Findings

DNA concentration, DNA purity, GAPDH Cp values, and BRAF gene Cp values were comparable between specimens from tumors ≤5 mm and tumors >5 mm (P=0.400, P=0.470, P=0.520, and P=0.460; respectively) and were not affected by FFPE block storage duration (P=0.380, P=0.500, P=0.140, and P=0.300; respectively). BRAF mutation status was successfully determined in 24/25 cases and there were no significant differences between the BRAF-negative (n=16) and BRAF-positive (n=8) tumor specimens in tumor size, tumor block storage duration, DNA concentration, or DNA purity (P=0.693, P=0.282, P=0.243, and P=0.458; respectively).

  • Biospecimens

    TissueThyroid Gland
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    DNAReal-time qPCR
    DNASpectrophotometry
    DNADNA sequencing
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPrognostic factor
    >5 mm tumor
    BRAF-negative tumor
    BRAF-positive tumor
    ≤5 mm tumor
    StorageStorage duration
    1 year
    2 years
    3 years
    4 years
    Real-time qPCR SpecificTargeted nucleic acid
    BRAF
    GAPDH